Related Experiment Video
Updated: Jul 13, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
CWC22-Mediated Alternative Splicing of Spp1 Regulates Nociception in Inflammatory Pain
Yu Song1, Zhi-Yong Wang2, Jun Luo3
1Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu Province 221004, China; Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, Jiangsu Province 221004, China; Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province 221002, China.
Abstract:
Increasing evidence suggests that alternative splicing plays a critical role in pain, but its underlying mechanism remains elusive. Herein, we employed complete Freund's adjuvant (CFA) to induce inflammatory pain in mice. A combination of genomics research techniques, lentivirus-based genetic manipulations, behavioral tests, and molecular biological technologies confirmed that splicing factor Cwc22 mRNA and CWC22 protein were elevated in the spinal dorsal horn at 3 days after CFA injection. Knockdown of spinal CWC22 by lentivirus transfection (lenti-shCwc22) reversed CFA-induced thermal hyperalgesia and mechanical allodynia, whereas upregulation of spinal CWC22 (lenti-Cwc22) in naïve mice precipitated pain. Comprehensive transcriptome and genome analysis identified the secreted phosphoprotein 1 (Spp1) as a potential gene of CWC22-mediated alternative splicing, however, only Spp1 splicing variant 4 (Spp1 V4) was involved in thermal and mechanical nociceptive regulation. In conclusion, our findings demonstrate that spinal CWC22 regulates Spp1 V4 to participate in CFA-induced inflammatory pain. Blocking CWC22 or CWC22-mediated alternative splicing may provide a novel therapeutic target for the treatment of persistent inflammatory pain.
Insights
This study reveals that elevated CWC22 in the spinal cord drives inflammatory pain by altering Spp1 V4 splicing. Reducing CWC22 alleviates pain, suggesting it as a therapeutic target for chronic pain conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alternative splicing is implicated in pain mechanisms, but the specific factors and pathways involved are not fully understood.
- Inflammatory pain models are crucial for investigating the molecular underpinnings of pain sensitization.
Purpose of the Study:
- To elucidate the role and mechanism of splicing factor CWC22 in the development of inflammatory pain.
- To identify specific splicing events regulated by CWC22 that contribute to nociception.
Main Methods:
- Induction of inflammatory pain in mice using complete Freund's adjuvant (CFA).
- Utilized lentivirus-mediated gene knockdown and overexpression of CWC22 in the spinal cord.
- Performed behavioral tests for thermal hyperalgesia and mechanical allodynia.
- Employed transcriptomic and genomic analyses to identify CWC22 targets.
Main Results:
- CWC22 mRNA and protein levels were significantly increased in the spinal dorsal horn following CFA injection.
- Knockdown of spinal CWC22 attenuated CFA-induced pain behaviors, while its upregulation induced pain in naive mice.
- Transcriptome analysis identified Spp1 as a CWC22-regulated gene, with Spp1 variant 4 (Spp1 V4) specifically linked to nociceptive regulation.
Conclusions:
- Spinal CWC22 plays a critical role in mediating inflammatory pain through the regulation of Spp1 V4 alternative splicing.
- Targeting CWC22 or its downstream splicing events presents a potential therapeutic strategy for managing persistent inflammatory pain.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nociception
RNA Splicing
Non-Canonical Wnt Signaling Pathways
Major Somatic Sensory Pathways
Pain

